LLL-12-B

N/A

Report date: 2026/01/22 16:42:33
NME

Base Information

Drug NameLLL-12-B
Drug Alias NameLLL-12-BLLL12B
ClassificationSmall molecules
Mechanisms of ActionSignal transducer and activator of transcription 3 inhibitors
TargetsSignal transducer and activator of transcription 3
Therapy Area/IndicationsTriple Negative Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Maryland, Baltimore
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of Maryland, Baltimore
Inactive CompaniesN/A
Active IndicationsTriple Negative Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A